What happened
Cytogen updated a previously disclosed supply contract, now worth US$790K, about 9.62% of its recent annual revenue, running through Dec 2026.
For context, this single contract equals about 9.62% of the company's most recent annual revenue.
| Counterparty | Disclosed |
|---|---|
| Contract value | US$790K |
| vs. recent revenue | 9.62% |
| Through | Dec 2026 (from Nov 2025) |
| Filed | 2026-10-20, [Amended] Supply contract signed (voluntary) |
| Source | DART rcept 20261020900620 → open original filing |
Source: DART. Information only, not investment advice.